BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 22539193)

  • 21. VPAC2-R mediates the lipolytic effects of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide in primary rat adipocytes.
    Akesson L; Ahrén B; Edgren G; Degerman E
    Endocrinology; 2005 Feb; 146(2):744-50. PubMed ID: 15514088
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhanced production of pituitary adenylate-cyclase-activating polypeptide by 1, N6-dibutyryladenosine 3',5'-monophosphate, phorbol 12-myristate 13-acetate and by the polypeptide itself in human neuroblastoma cells, IMR-32.
    Suzuki N; Harada M; Hosoya M; Fujino M
    Eur J Biochem; 1994 Jul; 223(1):147-53. PubMed ID: 7913440
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The expression of PAC1 increases in the degenerative thymus and low dose PACAP protects female mice from cyclophosphamide induced thymus atrophy.
    Zhang H; Yu R; Liu X; Guo X; Zeng Z
    Peptides; 2012 Dec; 38(2):337-43. PubMed ID: 23000307
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Developmental changes in the hypothalamic mRNA expression levels of PACAP and its receptor PAC1 and their sensitivity to fasting in male and female rats.
    Iwasa T; Matsuzaki T; Tungalagsuvd A; Munkhzaya M; Yiliyasi M; Kato T; Kuwahara A; Irahara M
    Int J Dev Neurosci; 2016 Aug; 52():33-7. PubMed ID: 27181029
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pituitary adenylate cyclase activating polypeptide (PACAP) in the rat mammary gland.
    Skakkebaek M; Hannibal J; Fahrenkrug J
    Cell Tissue Res; 1999 Oct; 298(1):153-9. PubMed ID: 10555549
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pituitary adenylate cyclase-activating polypeptide].
    Gonzalez BJ; Basille M; Vaudry D; Fournier A; Vaudry H
    Ann Endocrinol (Paris); 1998 Dec; 59(5):364-405. PubMed ID: 9949891
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypophysiotropic action of pituitary adenylate cyclase-activating polypeptide (PACAP) in the goldfish: immunohistochemical demonstration of PACAP in the pituitary, PACAP stimulation of growth hormone release from pituitary cells, and molecular cloning of pituitary type I PACAP receptor.
    Wong AO; Leung MY; Shea WL; Tse LY; Chang JP; Chow BK
    Endocrinology; 1998 Aug; 139(8):3465-79. PubMed ID: 9681497
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PAC1 receptors mediate pituitary adenylate cyclase-activating polypeptide- and progesterone-facilitated receptivity in female rats.
    Apostolakis EM; Riherd DN; O'Malley BW
    Mol Endocrinol; 2005 Nov; 19(11):2798-811. PubMed ID: 15976009
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pituitary adenylate cyclase-activating polypeptide-induced PAC1 receptor internalization and recruitment of MEK/ERK signaling enhance excitability of dentate gyrus granule cells.
    Johnson GC; Parsons RL; May V; Hammack SE
    Am J Physiol Cell Physiol; 2020 May; 318(5):C870-C878. PubMed ID: 32186931
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel splice variants of type I pituitary adenylate cyclase-activating polypeptide receptor in frog exhibit altered adenylate cyclase stimulation and differential relative abundance.
    Alexandre D; Vaudry H; Grumolato L; Turquier V; Fournier A; Jégou S; Anouar Y
    Endocrinology; 2002 Jul; 143(7):2680-92. PubMed ID: 12072402
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) Enhances Hippocampal Synaptic Plasticity and Improves Memory Performance in Huntington's Disease.
    Cabezas-Llobet N; Vidal-Sancho L; Masana M; Fournier A; Alberch J; Vaudry D; Xifró X
    Mol Neurobiol; 2018 Nov; 55(11):8263-8277. PubMed ID: 29526016
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pituitary adenylate cyclase-activating polypeptide expression and modulation of neuronal excitability in guinea pig cardiac ganglia.
    Braas KM; May V; Harakall SA; Hardwick JC; Parsons RL
    J Neurosci; 1998 Dec; 18(23):9766-79. PubMed ID: 9822736
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of pituitary adenylate cyclase-activating polypeptide (PACAP) and the PACAP-selective receptor in cultured rat astrocytes, human brain tumors, and in response to acute intracranial injury.
    Jaworski DM
    Cell Tissue Res; 2000 May; 300(2):219-30. PubMed ID: 10867818
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pituitary adenylyl cyclase-activating polypeptide (PACAP) and its receptor (PAC1-R) are positioned to modulate afferent signaling in the cochlea.
    Drescher MJ; Drescher DG; Khan KM; Hatfield JS; Ramakrishnan NA; Abu-Hamdan MD; Lemonnier LA
    Neuroscience; 2006 Sep; 142(1):139-64. PubMed ID: 16876955
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pituitary adenylate cyclase activating polypeptide and PAC1 receptor signaling increase Homer 1a expression in central and peripheral neurons.
    Girard BM; Keller ET; Schutz KC; May V; Braas KM
    Regul Pept; 2004 Dec; 123(1-3):107-16. PubMed ID: 15518900
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pituitary adenylate cyclase-activating peptide/vasoactive intestinal peptide receptors in human normal mammary gland and breast cancer tissue.
    García-Fernández MO; Collado B; Bodega G; Cortés J; Ruíz-Villaespesa A; Carmena MJ; Prieto JC
    Gynecol Endocrinol; 2005 Jun; 20(6):327-33. PubMed ID: 16019382
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impaired somatodendritic responses to pituitary adenylate cyclase-activating polypeptide (PACAP) of supraoptic neurones in PACAP type I -receptor deficient mice.
    Jamen F; Alonso G; Shibuya I; Widmer H; Vacher CM; Calas A; Bockaert J; Brabet P; Dayanithi G
    J Neuroendocrinol; 2003 Sep; 15(9):871-81. PubMed ID: 12899682
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuroleptic Drugs and PACAP Differentially Affect the mRNA Expression of Genes Encoding PAC1/VPAC Type Receptors.
    Jóźwiak-Bębenista M; Kowalczyk E
    Neurochem Res; 2017 Apr; 42(4):943-952. PubMed ID: 27900577
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification and functional properties of the pituitary adenylate cyclase activating peptide (PAC1) receptor in human benign hyperplastic prostate.
    Solano RM; Carmena MJ; Busto R; Sánchez-Chapado M; Guijarro LG; Prieto JC
    Cell Signal; 1999 Nov; 11(11):813-9. PubMed ID: 10617284
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PACAP38 and PAC
    Rubio-Beltrán E; Correnti E; Deen M; Kamm K; Kelderman T; Papetti L; Vigneri S; MaassenVanDenBrink A; Edvinsson L;
    J Headache Pain; 2018 Aug; 19(1):64. PubMed ID: 30088106
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.